Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
I
Isabelle Meyts
KU Leuven(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
435
Papers
26.0K
Citations
69
h-index
201
i10-index
Isabelle Meyts is an academic researcher from KU Leuven. The author has contributed to research in topics: Immunodeficiency and Autoimmune Disorders & Blood disorders and treatments & Immune Cell Function and Interaction. The author has an h-index of 69, co-authored 370 publications.
ORCID: 0000-0003-1214-0302Papers by this author
worksAutoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
2022 · Journal of Clinical Immunology · 1,078 citations
https://doi.org/10.1007/s10875-022-01289-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat